Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation (BetrnetRF)

This study is enrolling participants by invitation only.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Kenneth K. Wang, Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01568723
First received: March 29, 2012
Last updated: September 16, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: August 2020
  Estimated Primary Completion Date: August 2018 (Final data collection date for primary outcome measure)